Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medley Genomics
Providence, Rhode Island, United States
- Ownership
- Private
- Employees
- ~4
- Development stage
- Other
01
Overview
Medley Genomics develops software and analytics that interpret tumor genome sequencing data to quantify genomic heterogeneity and subclonal structure, supporting more precise initial treatment selection and combination therapies in oncology; it enables research and clinical decision support rather than developing its own therapeutic drugs[1][2][3][5].
- Therapeutic areas
- Oncology
- Industry
- Digital Health Medical Devices
02
Partnerships
Academic collaborations and proof‑of‑concept partnerships initiated using seed funding from Slater Technology Fund (specific partner names not publicly detailed)[3].
Beyond the preview
Go deeper on Medley Genomics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medley Genomics.